C063P: Ruplizumab Biosimilar (Research Grade), Anti-human CD40L Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade ruplizumab biosimilar specifically binds to the human CD40L.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by ruplizumab.C059P: Mirvetuximab Biosimilar, Human FOLR1 Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The monoclonal antibody mirvetuximab biosimilar specifically binds to the human FOLR1 protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by mirvetuximab.C058P: Ibalizumab Biosimilar, Human CD4 Monoclonal Antibody
Recombinant Humanized IgG4 Monoclonal Antibody.
Specificity/Sensitivity: The monoclonal antibody ibalizumab biosimilar specifically binds to the human CD4 protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by ibalizumab.C056P: Teplizumab Biosimilar, CD3 Monoclonal Antibody
Recombinant human IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade teplizumab biosimilar specifically binds to the human T cell receptor CD3.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by teplizumab.C036P: Foralumab Biosimilar, CD3 Monoclonal Antibody
Recombinant human IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade foralumab biosimilar specifically binds to the human T cell receptor CD3.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by foralumab.C054P: Muromonab Biosimilar, CD3 Monoclonal Antibody
Recombinant mouse IgG2a Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade muromonab biosimilar specifically binds to the human T cell receptor CD3.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by muromonab.C074P: Semaglutide Biosimilar
Source: The recombinant peptide semaglutide biosimilar was produced in the semaglutide stable cell line.
Applications: ELISA, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by semaglutide.
Endotoxin: < 1 EU per 1 mg of the protein by the LAL method.
Purity: >95% by SDS-PAGE under reducing conditions and HPLC.C074PS: Semaglutide Synthetic Peptide
Source: The semaglutide peptide was synthesized.
Applications: ELISA, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by semaglutide.
Purity: >95% by SDS-PAGE under reducing conditions and HPLC.C071P: Sacituzumab Biosimilar, Human Trop-2 Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The monoclonal antibody sacituzumab biosimilar specifically binds to the human Trop-2 protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by sacituzumab.C009P: Trastuzumab Biosimilar, HER2/ErbB-2/c-neu Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The monoclonal antibody trastuzumab biosimilar specifically binds to the human HER2 / ErbB-2 / c-neu.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by trastuzumab.C002P: Cetuximab Biosimilar, Human EGFR Monoclonal Antibody
Recombinant Chimeric IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The monoclonal antibody cetuximab biosimilar specifically binds to the human EGFR.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by cetuximab.